Drug Reduces Graft-Versus-Host After Stem Cell Transplant
Doctors Lounge
The chemokine receptor CCR5 antagonist maraviroc, which blocks lymphocyte trafficking, is safe and reduces the incidence of acute graft-versus-host disease in patients undergoing allogeneic hematopoietic stem-cell transplantation, according to a phase ...
Drug Staves Off Graft-vs-Host DiseaseMedPage Today
Maraviroc reduces incidence of GvHD in blood cancer patients after bone ...News-Medical.net
HIV Drug May Prevent Bone Marrow Transplant ComplicationiVillage Entertainment
Pittsburgh Post Gazette
all 19 news articles »